Loading...
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
AIM: Sacubitril-valsartan has proven beneficial in heart failure with reduced ejection fraction. Guidelines recommend initiating half-dose sacubitril-valsartan before up-titration even to patients already on target dose angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers...
Saved in:
| Published in: | Cardiovasc Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Hindawi
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6739794/ https://ncbi.nlm.nih.gov/pubmed/31772613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6745074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|